The 5 categories in the cannabis sector perform quite differently from each other and below is a summary of how each category performed last week and YTD, in descending order:

1. The Ancillary Pot Stock Index: DOWN 11.4% last week; UP 1.5% YTD
   • The Index consists of the 7 largest companies providing goods and services to the cannabis sector, namely, AFC Gamma  (AFCG); Forian (FORA);  Hydrofarm (HYFM); GrowGeneration (GRWG); Innovative Industrial Properties (IIPR);  Scotts Miracle-Gro Company (SMG) and Turning Point Brands (TPB).
   • The constituent stocks trade for at least US$2/share on the Canadian and/or American stock exchanges and have market caps of at least US$90M.
2. The Conservative Pot Stocks Index: DOWN 3.3% last week; DOWN 4.4% YTD
   • The Index consists of 6 tobacco, beer, and liquor companies that have invested heavily in the cannabis industry, namely, Altria Group (MO); Anheuser-Busch  (BUD); British American Tobacco (BTI); Constellation Brands (STZ);  Imperial Brands (IMBBY) and Molson Coors Brewing Company (TAP).
   • The constituent stocks all pay dividends with yields ranging from just 0.9% for Anheuser Busch to 8.4% for Altria and average out at 3.1%.
3. The American Cannabis MSOs Index: DOWN 3.9% last week; DOWN 6.5% YTD 
   • The Index consists of the 12 largest American Multi-State Operators, namely, Acreage (ACRDF/ACRHF); Ascend Wellness (AAWH); Ayr Wellness (AYRWF); Columbia Care (CCHWF); Cresco (CRLBF); Curaleaf (CURLF); Green Thumb (GTBIF);  Jushi (JUSHF); Planet 13 (PLNHF); TerrAscend (TRSSF); Trulieve (TCNNF) and Verano  (VRNOF).
   • The constituent stocks trade for at least US$1/share on the Canadian and/or American stock exchanges and have market caps of at least US$75M.
4. The Psychedelic Drug Stocks Index: DOWN 13.4% last week; DOWN 6.7% YTD
   • The Index consists of 7 psychedelic compound-based and marijuana (THC) drug companies in the clinical stages of research and development of treatments for a wide variety of mental illnesses, namely Cybin (CYBN); Atai (ATAI); Seelos (SEEL), Compass Pathway (CMPS); Mind Medicine (MNMD), GH Resources (GHRS) and newest addition to the list Incannex Healthcare (IXHL).
   • The constituent stocks trade on the Canadian and/or American stock exchanges and have market caps of at least US$70M.
5. The Canadian Cannabis LPs Index: DOWN 13.2%; DOWN 14.6% YTD
   • The Index consists of the 5 largest Canadian Licensed Producers, namely: Aurora (ACB); Canopy Growth (CGC); Cronos (CRON); Organigram (OGI), and Tilray (TLRY).
   • The constituent stocks  trade for at least US$1/share on the Canadian and/or American stock exchanges and have market caps in excess of US$250M.

In summary, the 5 cannabis/cannabis-related company stock category performances ranged from: +1.5% to -14.6% YTD.

More By This Author:

5 Largest Canadian Cannabis LPs - 13% This Week; -26% In Last 6 Weeks
Ayr Wellness Q4 Financials: Operating Loss Increases; EBITDA Improves
MindMed: Researching LSD And MNMA To Treat Neurological Diseases